Lantheus Holdings, Inc. (LNTH)
Market Closed
3 Jun, 20:00
$
100. 25
+3.95
+4.1%
$
6.32B Market Cap
50.69 P/E Ratio
- Div Yield
1,071,746 Volume
5.84 Eps
$ 96.3
Previous Close Investors:
Want to track LNTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Here's Why Lantheus Holdings (LNTH) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks | 2 years ago
Leading The Growth Of Radiopharmaceuticals: Mini Deep Dive On Lantheus
Lantheus Holdings, Inc. excels in radiopharmaceuticals, with PYLARIFY's dominance in PSMA PET imaging. The market for radiopharmaceuticals is expanding beyond all expectations by both industry experts and the company's management. Lantheus is actively expanding its pipeline by making strategic investments backed by a robust balance sheet.
Seekingalpha | 2 years ago
